Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moniek Schouten

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cannabis and Cannabinoid Research|January 3, 2022
<i>Letter to the Editor:</i> The Receptor(s) via Which Cannabidiol Affects Muscle Signaling: In Need for More InsightsSebastiaan Dalle, Moniek Schouten, Katrien Koppo
Cannabis and Cannabinoid Research|December 1, 2022
Molecular Mechanisms Through Which Cannabidiol May Affect Skeletal Muscle Metabolism, Inflammation, Tissue Regeneration, and Anabolism: A Narrative ReviewMoniek Schouten, Sebastiaan Dalle, Katrien Koppo
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 31, 2025
The muscle protein density associates with radiodensity, strength, damage, unloading, and disease: evidence from humans and miceMoniek Schouten, Ruud Van Thienen, Sebastiaan Dalle
Frontiers in Pharmacology|January 30, 2024
Cannabidiol and brain function: current knowledge and future perspectivesMoniek Schouten, Sebastiaan Dalle, Dante Mantini, et al.
Molecular and Cellular Endocrinology|January 22, 2023
The cannabinoid receptor 1 antagonist AM6545 stimulates the Akt-mTOR axis and in vivo muscle protein synthesis in a dexamethasone-induced muscle atrophy modelSebastiaan Dalle, Moniek Schouten, Monique Ramaekers, et al.
Journal of Cellular Physiology|July 21, 2022
Molecular networks underlying cannabinoid signaling in skeletal muscle plasticitySebastiaan Dalle, Moniek Schouten, Gitte Meeus, et al.
Toxicology and Applied Pharmacology|August 31, 2024
The molecular signature of the peripheral cannabinoid receptor 1 antagonist AM6545 in adipose, liver and muscle tissueSebastiaan Dalle, Moniek Schouten, Jolien Deboutte, et al.
Frontiers in Physiology|January 30, 2023
Effect of increased protein intake and exogenous ketosis on body composition, energy expenditure and exercise capacity during a hypocaloric diet in recreational female athletesCharlotte Hiroux, Moniek Schouten, Isabelle de Glisezinski, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 28, 2025
Rimonabant treatment partly attenuates skeletal muscle loss following immobilization in young and in old, sarcopenic male miceSebastiaan Dalle, Kaat Vanderbeke, Moniek Schouten, et al.
Life Sciences|December 7, 2024
The CB1 antagonist Rimonabant improves muscle regeneration and remodels the inflammatory and endocannabinoid profile upon injury in male miceSebastiaan Dalle, Moniek Schouten, Kaat Vanderbeke, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cannabis and Cannabinoid Research|January 3, 2022
<i>Letter to the Editor:</i> The Receptor(s) via Which Cannabidiol Affects Muscle Signaling: In Need for More InsightsSebastiaan Dalle, Moniek Schouten, Katrien Koppo
Cannabis and Cannabinoid Research|December 1, 2022
Molecular Mechanisms Through Which Cannabidiol May Affect Skeletal Muscle Metabolism, Inflammation, Tissue Regeneration, and Anabolism: A Narrative ReviewMoniek Schouten, Sebastiaan Dalle, Katrien Koppo
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 31, 2025
The muscle protein density associates with radiodensity, strength, damage, unloading, and disease: evidence from humans and miceMoniek Schouten, Ruud Van Thienen, Sebastiaan Dalle
Frontiers in Pharmacology|January 30, 2024
Cannabidiol and brain function: current knowledge and future perspectivesMoniek Schouten, Sebastiaan Dalle, Dante Mantini, et al.
Molecular and Cellular Endocrinology|January 22, 2023
The cannabinoid receptor 1 antagonist AM6545 stimulates the Akt-mTOR axis and in vivo muscle protein synthesis in a dexamethasone-induced muscle atrophy modelSebastiaan Dalle, Moniek Schouten, Monique Ramaekers, et al.
Journal of Cellular Physiology|July 21, 2022
Molecular networks underlying cannabinoid signaling in skeletal muscle plasticitySebastiaan Dalle, Moniek Schouten, Gitte Meeus, et al.
Toxicology and Applied Pharmacology|August 31, 2024
The molecular signature of the peripheral cannabinoid receptor 1 antagonist AM6545 in adipose, liver and muscle tissueSebastiaan Dalle, Moniek Schouten, Jolien Deboutte, et al.
Frontiers in Physiology|January 30, 2023
Effect of increased protein intake and exogenous ketosis on body composition, energy expenditure and exercise capacity during a hypocaloric diet in recreational female athletesCharlotte Hiroux, Moniek Schouten, Isabelle de Glisezinski, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 28, 2025
Rimonabant treatment partly attenuates skeletal muscle loss following immobilization in young and in old, sarcopenic male miceSebastiaan Dalle, Kaat Vanderbeke, Moniek Schouten, et al.
Life Sciences|December 7, 2024
The CB1 antagonist Rimonabant improves muscle regeneration and remodels the inflammatory and endocannabinoid profile upon injury in male miceSebastiaan Dalle, Moniek Schouten, Kaat Vanderbeke, et al.
Pageof 2